JIR
ATRS

James Investment Research’s Antares Pharma, Inc. ATRS Stock Holding History

James Investment Research’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-56,200
Closed -$230K – 560
2022
Q1 		$230K Buy
+56,200
New +$204K 0.02% 266

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

James Investment Research's ATRS Position: Q2 2022 in Review

James Investment Research sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 56,200 shares — an estimated $230K sold.

James Investment Research first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $230K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • James Investment Research reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • James Investment Research sold 56,200 Antares Pharma, Inc. shares in Q2 2022, an estimated $230K.
  • James Investment Research first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • James Investment Research's Antares Pharma, Inc. position peaked at $230K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on James Investment Research's 13F filing for Q2 2022, filed 1 Aug 2022.